Evidence map›Paper›PMID 32023327›Full record

ArticlePLoS pathogens2020

Selective reconstitution of IFN‑γ gene function in Ncr1+ NK cells is sufficient to control systemic vaccinia virus infection.

Katharina Borst, Sven Flindt, Patrick Blank, Pia-Katharina Larsen, Chintan Chhatbar, Jennifer Skerra, Julia Spanier, Christoph Hirche, Martin König, Tomas Alanentalo and 8 more

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 19 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Review
  5. Article
  6. IL-15 Priming Alters IFN-γ Regulation in Murine NK Cells.Journal of immunology (Baltimore, Md. : 1950) · 2023
    Article
  7. Antiviral Activities of Group I Innate Lymphoid Cells.Journal of molecular biology · 2022
    Review
  8. Review
  9. Review
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 8 institutions in 3 countries.

Katharina BorstTWINCORE-Centre for Experimental and Clinical Infection Research, Institute for Experimental Infection Research, Hanover, Germany.ORCID 0000-0002-2999-2360
Sven FlindtPaul-Ehrlich-Institut, Division of Immunology, Langen, Germany.
Patrick BlankTWINCORE-Centre for Experimental and Clinical Infection Research, Institute for Experimental Infection Research, Hanover, Germany.ORCID 0000-0002-0457-1738
Pia-Katharina LarsenTWINCORE-Centre for Experimental and Clinical Infection Research, Institute for Experimental Infection Research, Hanover, Germany.ORCID 0000-0001-6425-3208
Chintan ChhatbarTWINCORE-Centre for Experimental and Clinical Infection Research, Institute for Experimental Infection Research, Hanover, Germany.ORCID 0000-0002-5824-5209
Jennifer SkerraTWINCORE-Centre for Experimental and Clinical Infection Research, Institute for Experimental Infection Research, Hanover, Germany.ORCID 0000-0002-8845-7683
Julia SpanierTWINCORE-Centre for Experimental and Clinical Infection Research, Institute for Experimental Infection Research, Hanover, Germany.ORCID 0000-0002-8797-3563
Christoph HircheTWINCORE-Centre for Experimental and Clinical Infection Research, Institute for Experimental Infection Research, Hanover, Germany.
Martin KönigPaul-Ehrlich-Institut, Division of Immunology, Langen, Germany.
Tomas AlanentaloEuropean Molecular Biology Laboratory (EMBL), Mouse Biology Programme, Monterodonto, Italy.ORCID 0000-0001-5714-0344
Martin HafnerHelmholtz Centre for Infection Research, Brunswick, Germany.ORCID 0000-0003-0769-1812
Zoe WaiblerPaul-Ehrlich-Institut, Division of Immunology, Langen, Germany.
Klaus PfefferUniversity of Düsseldorf, Institute of Medical Microbiology and Hospital Hygiene, Düsseldorf, Germany.ORCID 0000-0002-5652-6330
Veronika SexlUniversity of Veterinary Medicine (VetmedUni), Institute for Pharmacology and Toxicology, Vienna, Austria.
Gerd SutterLMU University of Munich, Institute for Infectious Diseases and Zoonoses, Munich, Germany.ORCID 0000-0001-6143-082X
Werner MüllerHelmholtz Centre for Infection Research, Brunswick, Germany.ORCID 0000-0002-1297-9725
Theresa GraalmannTWINCORE-Centre for Experimental and Clinical Infection Research, Institute for Experimental Infection Research, Hanover, Germany.
Ulrich KalinkeTWINCORE-Centre for Experimental and Clinical Infection Research, Institute for Experimental Infection Research, Hanover, Germany.ORCID 0000-0003-0503-9564
Center for Experimental and Clinical Infection Research · DEPaul Ehrlich Institut · DEHelmholtz Centre for Infection Research · DEMedizinische Hochschule Hannover · DEDüsseldorf University Hospital · DEEuropean Molecular Biology Laboratory · ITLudwig-Maximilians-Universität München · DEUniversity of Veterinary Medicine Vienna · AT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

IFN-γ is an enigmatic cytokine that shows direct anti-viral effects, confers upregulation of MHC-II and other components relevant for antigen presentation, and that adjusts the composition and balance of complex cytokine responses. It is produced during immune responses by innate as well as adaptive immune cells and can critically affect the course and outcome of infectious diseases, autoimmunity, and cancer. To selectively analyze the function of innate immune cell-derived IFN-γ, we generated conditional IFN-γOFF mice, in which endogenous IFN-γ expression is disrupted by a loxP flanked gene trap cassette inserted into the first intron of the IFN-γ gene. IFN-γOFF mice were intercrossed with Ncr1-Cre or CD4-Cre mice that express Cre mainly in NK cells (IFN-γNcr1-ON mice) or T cells (IFN-γCD4-ON mice), respectively. Rosa26RFP reporter mice intercrossed with Ncr1-Cre mice showed selective RFP expression in more than 80% of the NK cells, while upon intercrossing with CD4-Cre mice abundant RFP expression was detected in T cells, but also to a minor extent in other immune cell subsets. Previous studies showed that IFN-γ expression is needed to promote survival of vaccinia virus (VACV) infection. Interestingly, during VACV infection of wild type and IFN-γCD4-ON mice two waves of serum IFN-γ were induced that peaked on day 1 and day 3/4 after infection. Similarly, VACV infected IFN-γNcr1-ON mice mounted two waves of IFN-γ responses, of which the first one was moderately and the second one profoundly reduced when compared with WT mice. Furthermore, IFN-γNcr1-ON as well as IFN-γCD4-ON mice survived VACV infection, whereas IFN-γOFF mice did not. As expected, ex vivo analysis of splenocytes derived from VACV infected IFN-γNcr1-ON mice showed IFN-γ expression in NK cells, but not T cells, whereas IFN-γOFF mice showed IFN-γ expression neither in NK cells nor T cells. VACV infected IFN-γNcr1-ON mice mounted normal cytokine responses, restored neutrophil accumulation, and showed normal myeloid cell distribution in blood and spleen. Additionally, in these mice normal MHC-II expression was detected on peripheral macrophages, whereas IFN-γOFF mice did not show MHC-II expression on such cells. In conclusion, upon VACV infection Ncr1 positive cells including NK cells mount two waves of early IFN-γ responses that are sufficient to promote the induction of protective anti-viral immunity.

Indexed as

AnimalsAntigens, LyGene Expression RegulationHistocompatibility Antigens Class IIInterferon-gammaKiller Cells, NaturalMiceMice, TransgenicNatural Cytotoxicity Triggering Receptor 1T-LymphocytesVacciniaVaccinia virusAntigens, LyHistocompatibility Antigens Class IIIFNG protein, mouseInterferon-gammaNatural Cytotoxicity Triggering Receptor 1Ncr1 protein, mouse

Identifiers

PMID32023327
PMCPMC7028289
OpenAlexW3005456357

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.